Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Disease Types: Colon

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

For more information:

https://clinicaltrials.gov/ct2/show/NCT05425940?term=Study+of+XL092+%2B+Atezolizumab+vs+Regorafenib+in+Subjects+With+Metastatic+Colorectal+Cancer&draw=2&rank=1